Open live CFD account Try free demo
Call: 1800 885 571 Mail: support@gomarkets.com
Login Open account
Login Open account
Login Open account
News & analysis
Try free demo Open account
News & analysis
Try free demo Open account

Pfizer Q4 results announced

9 February 2022 By Klavs Valters

Share

Pfizer Inc. (PFE) reported its Q4 financial results before the market open on Wall Street on Tuesday.

The world’s third largest pharmaceutical company reported total revenue of $23.838 billion in the previous quarter (105% increase from the same period in 2020), falling short of analyst forecast of $24.157 billion.

Earnings per share reported at $1.08 (152% increase from the same period in 2020) vs. $0.87 per share expected.

Dr. Albert Bourla, Chairman and CEO, outlined the work the company has done against COVID-19 over the past two years following the latest financial results: ”In the early days of the COVID-19 pandemic, we committed to use all of the resources and expertise we had at our disposal to help protect populations globally against this deadly virus, as well as to offer treatments to help avoid the worst outcomes when infections do occur. We put billions of dollars of capital on the line in pursuit of those goals, not knowing whether those investments would ever pay off. Now, less than two years since we made that commitment, we are proud to say that we have delivered both the first FDA-authorized vaccine against COVID-19 (with our partner, BioNTech) and the first FDA-authorized oral treatment for COVID-19.”

”These successes have not only made a positive difference in the world, but I believe they have fundamentally changed Pfizer and its culture forever. Everywhere I look in the company, I see colleagues who are inspired by what we have achieved to date and filled with determination to be part of the next breakthrough that could change the world for patients in need. As we enter a new year, I look forward to all we will accomplish together,” Dr. Bourla added.

Pfizer Inc. (PFE) chart (Weekly)

Shares of Pfizer fell during the trading day on Tuesday, down by around 3% at $51.37 per share. Here is how the stock has performed in the past year –

  • 1 Month: -8.87%
  • 3 Month: +9.22%
  • Year-to-date: -12.51%
  • 1 Year: +47.97%

Pfizer is the 28th largest company in the world, with a total market cap of $ 282.77 billion.

You can trade Pfizer Inc. (PFE) and many other stocks from the NYSE, NASDAQ, HKEX and the ASX with GO Markets as a Share CFD.

Sources: Pfizer Inc., TradingView, CompaniesMarketCap

Ready to start trading?

Try free demo Open account

The information provided is of general nature only and does not take into account your personal objectives, financial situations or needs. Before acting on any information provided, you should consider whether the information is suitable for you and your personal circumstances and if necessary, seek appropriate professional advice. All opinions, conclusions, forecasts or recommendations are reasonably held at the time of compilation but are subject to change without notice. Past performance is not an indication of future performance. Go Markets Pty Ltd, ABN 85 081 864 039, AFSL 254963 is a CFD issuer, and trading carries significant risks and is not suitable for everyone. You do not own or have any interest in the rights to the underlying assets. You should consider the appropriateness by reviewing our TMD, FSG, PDS and other CFD legal documents to ensure you understand the risks before you invest in CFDs. These documents are available here.

#Economy #Economics #Finance #Markets